On Topic Virtual Roundtable: The Expanding Therapeutic Landscape for Targeting BCMA in Patients with Multiple Myeloma
On Topic Virtual Roundtable: The Expanding Therapeutic Landscape for Targeting BCMA in Patients with Multiple Myeloma is organized by Bio Ascend LLC.
Release Date: March 17, 2023
Expiration Date: March 17, 2024
Program Overview :
On Topic Virtual Roundtable: The Expanding Therapeutic Landscape for Targeting BCMA in Patients with Multiple Myeloma aims to provide clinical data regarding current and emerging therapeutic BCMA-directed treatment strategies via a panel of experts.
Learning Objectives:
• Discuss patient-related and disease-related factors that impact the selection of therapy for patients with relapsed/refractory MM
• Review the rationale for targeting BCMA in patients with MM, as well as current and emerging approaches that target BCMA, including CAR T-cells, bispecific antibodies, and antibody-drug conjugates
• Evaluate strategies to manage adverse events that may be encountered with the use of anti-BCMA therapies
Topics of Discussion:
Module 1: Introduction and Rationale for Targeting BCMA on MM Cells
Module 2: BCMA-Targeted CAR T-cells
Module 3: BCMA-Targeted Antibody-Drug Conjugates (ADCs)
Module 4: BCMA-Targeted Bispecifics